Company 1 identity field
Location
Denver, CO
SEC filing record 1 source field
Fiscal year end
30 June
AYTU BIOPHARMA, INC has filed 893 SEC EDGAR filings since 11 Jan 2007

SEC filing history

Showing 1-19 of 19 matching filings.

Per page
25
Current page
1
10-K File 001-38247

ANNUAL REPORT

Filing date
06 Oct 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
10-K File 001-38247

ANNUAL REPORT

Filing date
26 Sep 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-K File 001-38247

ANNUAL REPORT

Filing date
06 Sep 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
10-K/A File 001-38247

AMENDMENT NO. 2

Filing date
19 Oct 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-53121

FORM 10-K/A

Filing date
12 Oct 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-53121

ANNUAL REPORT

Filing date
26 Nov 2014
Reporting date
31 Aug 2014
Next action
Verify source filing
10-K File 000-53121

ANNUAL REPORT

Filing date
26 Nov 2013
Reporting date
31 Aug 2013
Next action
Verify source filing
10-K File 000-53121

ANNUAL REPORT

Filing date
29 Nov 2012
Reporting date
31 Aug 2012
Next action
Verify source filing
10-K File 000-53121

ANNUAL REPORT FOR YEAR ENDED 8-31-2010

Filing date
29 Nov 2011
Reporting date
31 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-53121

ANNUAL REPORT FOR YEAR ENDED 8-31-2010

Filing date
23 Nov 2010
Reporting date
31 Aug 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .